Pfizer Inc
PFE· NYSE
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Revenue | $12.68B | $13.30B | $13.17B | $13.05B |
| Net Income | $7.68B | $4.11B | $2.84B | $1.36B |
| EPS Diluted | $1.36 |
Pfizer Inc · CIK 78003 · Engraved from SEC EDGAR
| $0.69 |
| $0.47 |
| $0.22 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.